–
BridgeBio Oncology Therapeutics, Inc.
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25
(positive)
Change from FY24 to FY25
millions USD
FY23:
FY24:
−55.0
FY25:
−114
Change from FY23 to FY25
millions USD
FY23:
−2.82
FY24:
−121
FY25:
73.3
Change from FY23 to FY25
millions USD
FY23:
55.1
FY24:
206
FY25:
383
(positive)
Change from FY23 to FY25
millions USD
FY23:
−52.5
FY24:
−55.1
FY25:
−115
All amounts in millions USD FY23: figures supplemented from Twelve Data because the SEC filings do not reach back this far.